We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Thermoplastic Vertebral Body Replacement

By HospiMedica staff writers
Posted on 28 Dec 2005
A thermoplastic vertebral body replacement is designed to facilitate fusion in the thoracic or lumbar spine. More...
It has been cleared by the U.S. Food and Drug Administration (FDA).

The Graftcage ACX, developed by Osteotech (Eatontown, NJ, USA), is manufactured from polyetheretherketone (PEEK), a polymer that is an exceptionally strong engineering thermoplastic. Implantable-grade PEEK polymer is characterized by its biocompatibility and its biostability.

The GraftCage is intended to restore the height of a collapsed vertebral body, and is intended to replace a collapsed, damaged, or unstable vertebral body in the thoracic or lumbar spine. It is indicated for a partial or total vertebrectomy in cases of tumor or trauma-related damage to the vertebral body.

The GraftCage features titanium markers to facilitate intra-operative and post-operative radiographic assessments and an opening for the insertion of bone grafting materials, including a new form of the recently introduced Xpanse bone insert, also from Osteotech, to allow for maximum graft exposure.

This new version of the Xpanse bone insert is expected to be launched concurrently with the launch of the GraftCage. Used together, they create a vertebral body spacer allowing for maximum end-plate contact, structural support, osteoinductivity and osteoconductivity, the four key functional requirements for a successful fusion.

"The GraftCage ACX is the first in a series of new products from Osteotech manufactured from PEEK,” said Sam Owusu-Akyaw, president and chief operating officer of Osteotech. The company expects to introduce more PEEK products into the overall spinal interbody market over the course of 2006.




Related Links:
Osteotech

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.